{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T18:35:43Z","timestamp":1787337343537,"version":"build-2736575974"},"reference-count":12,"publisher":"Ovid Technologies (Wolters Kluwer Health)","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n                    <jats:title>Objectives:<\/jats:title>\n                    <jats:p>Acute metabolic acidosis is frequent in critical illness and may be managed with volume replacement therapy, sodium bicarbonate, and renal replacement therapy (RRT). BICARICU-1 and BICARICU-2 trials provided new evidence on bicarbonate therapy. We aimed to systematically evaluate the effects of sodium bicarbonate in critically ill patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Data Sources:<\/jats:title>\n                    <jats:p>We systematically searched PubMed, Embase, Medline, and the Cochrane Library for randomized controlled trials (RCTs) evaluating sodium bicarbonate vs. placebo in critically ill adults with acute metabolic acidosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Study Selection:<\/jats:title>\n                    <jats:p>Only RCTs were selected.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Data Extraction:<\/jats:title>\n                    <jats:p>Primary outcome was RRT; secondary outcomes were mortality, ICU length of stay, ventilator-free days, and vasopressor-free days.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Data Synthesis:<\/jats:title>\n                    <jats:p>We performed Hartung-Knapp random-effects meta-analyses and trial sequential analysis (TSA) for primary outcomes. Bayesian random-effects meta-analyses with noninformative and weakly informative priors were used for sensitivity analysis. Four trials enrolling 1,111 patients were included. Sodium bicarbonate showed a nonsignificant trend toward lower mortality (risk ratio [RR], 0.84; 95% CI, 0.55\u20131.30); TSA indicated that the cumulative sample size remained far below the required information size, and the mortality effect is inconclusive. Sodium bicarbonate significantly reduced RRT use (RR, 0.69; 95% CI, 0.61\u20130.78), and TSA supported firm evidence of benefit. Bayesian analyses estimated posterior probabilities of any mortality reduction (RR &lt; 1) and reduced RRT use of 90.4% and 94.6%, respectively. Secondary outcomes remained imprecise, with a trend of toward more vasopressor-free days.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>In critically ill adults with acute metabolic acidosis, sodium bicarbonate significantly reduces RRT requirement, with Bayesian analyses suggesting a possibility of mortality benefit, although current evidence remains inconclusive. Larger RCTs or high-quality real-world studies are needed to confirm efficacy of sodium bicarbonate for mortality.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/ccm.0000000000007179","type":"journal-article","created":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T14:00:15Z","timestamp":1779458415000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Sodium Bicarbonate for Acute Metabolic Acidosis in Critically Ill Adults: A Meta-Analysis of Randomized Clinical Trials"],"prefix":"10.1097","author":[{"given":"Jia-Jin","family":"Chen","sequence":"first","affiliation":[{"name":"Kidney Research Center, Department of Nephrology, Chang Gung Memorial Hospital, Taoyuan city, Taiwan."},{"name":"College of Medicine, Chang Gung University, Taoyuan city, Taiwan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao-Han","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Chansn Hospital, Taoyuan City, Taiwan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Hsiang","family":"Chang","sequence":"additional","affiliation":[{"name":"Kidney Research Center, Department of Nephrology, Chang Gung Memorial Hospital, Taoyuan city, Taiwan."},{"name":"College of Medicine, Chang Gung University, Taoyuan city, Taiwan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-Chun","family":"Lai","sequence":"additional","affiliation":[{"name":"Education Center, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Kang","family":"Tu","sequence":"additional","affiliation":[{"name":"Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University, Taipei, Taiwan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0884-9098","authenticated-orcid":false,"given":"Yen-Ta","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Surgery, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,5,22]]},"reference":[{"key":"R1-20260821","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/nrneph.2010.33","article-title":"Metabolic acidosis: Pathophysiology, diagnosis and management.","volume":"6","author":"Kraut","year":"2010","journal-title":"Nat Rev Nephrol"},{"key":"R2-20260821","first-page":"e4297","article-title":"Bicarbonate therapy for critically ill patients with metabolic acidosis: A systematic review.","volume":"11","author":"Ghauri","year":"2019","journal-title":"Cureus"},{"key":"R3-20260821","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1007\/s00134-025-07979-x","article-title":"Sodium bicarbonate administration for metabolic acidosis in the intensive care unit: A target trial emulation.","volume":"51","author":"Blank","year":"2025","journal-title":"Intensive Care Med"},{"key":"R4-20260821","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/1471-2334-8-50","article-title":"Effects of resuscitation with crystalloid fluids on cardiac function in patients with severe sepsis.","volume":"8","author":"Fang","year":"2008","journal-title":"BMC Infect Dis"},{"key":"R5-20260821","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.jcrc.2019.02.027","article-title":"Sodium bicarbonate therapy for critically ill patients with metabolic acidosis: A scoping and a systematic review.","volume":"51","author":"Fujii","year":"2019","journal-title":"J Crit Care"},{"key":"R6-20260821","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.hrtlng.2019.10.007","article-title":"Bicarbonate use and mortality outcome among critically ill patients with metabolic acidosis: A meta analysis.","volume":"49","author":"Lo","year":"2020","journal-title":"Heart Lung"},{"key":"R7-20260821","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1001\/jama.2025.20231","article-title":"Sodium bicarbonate for severe metabolic acidemia and acute kidney injury: The BICARICU-2 randomized clinical trial.","volume":"334","author":"Jung","year":"2025","journal-title":"JAMA"},{"key":"R8-20260821","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(18)31080-8","article-title":"Sodium bicarbonate therapy for patients with severe metabolic acidaemia in the intensive care unit (BICAR-ICU): A multicentre, open-label, randomised controlled, phase 3 trial.","volume":"392","author":"Jaber","year":"2018","journal-title":"Lancet"},{"key":"R9-20260821","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1001\/jamaoto.2022.2847","article-title":"Avoiding definitive conclusions in meta-analysis of heterogeneous studies with small sample sizes.","volume":"148","author":"Zhou","year":"2022","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"R10-20260821","first-page":"24","article-title":"The use of sodium bicarbonate in stages in treating hypoperfusion induced lactic acidemia in septic shock.","volume":"25","author":"Chen","year":"2013","journal-title":"Zhonghua Wei Zhong Bing Ji Jiu Yi Xue"},{"key":"R11-20260821","doi-asserted-by":"crossref","first-page":"e221","DOI":"10.1097\/CCM.0000000000005955","article-title":"Sodium bicarbonate for metabolic acidosis in the ICU: Results of a pilot randomized double-blind clinical trial.","volume":"51","author":"Neto","year":"2023","journal-title":"Crit Care Med"},{"key":"R12-20260821","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s13054-025-05307-9","article-title":"Death by p-value: the overreliance on p-values in critical care research.","volume":"29","author":"Patel","year":"2025","journal-title":"Crit Care"}],"container-title":["Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/CCM.0000000000007179","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T18:00:12Z","timestamp":1787335212000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/CCM.0000000000007179"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,22]]},"references-count":12,"URL":"https:\/\/doi.org\/10.1097\/ccm.0000000000007179","relation":{},"ISSN":["0090-3493","1530-0293"],"issn-type":[{"value":"0090-3493","type":"print"},{"value":"1530-0293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,22]]}}}